A novel self-assembled pH-sensitive targeted nanoparticle platform based on antibody–4arm-polyethylene glycol–pterostilbene conjugates for co-delivery of anticancer drugs
Source abstract
Abstract
Recently, antibody-drug conjugates (ADC) have shown potential for cancer immunotherapy by tumor-targeted delivery of anticancer drugs. However, the development of ADC is subject to many restrictions, such as the payloads, stabilities and intracellular uptake of the drugs, which has greatly restricted their clinical application. To overcome these hurdles, in this study, a novel pH-sensitive targeted nanoparticle platform based on a newly synthesized amphipathic antibody-drug conjugate (antibody-4arm-polyethylene glycol-pterostilbene, mAb-4arm-PEG-PS) was fabricated for co-delivery of another anticancer drug (10-hydroxy camptothecin, HCPT). The prepared mAb-4arm-PEG-PS/HCPT nanoparticles (NPs) had a moderate particle size (∼120 nm), a high drug to antibody ratio (∼22.4) and relatively high binary drug loading capacity (∼24.2 wt% HCPT, ∼2.9 wt% PS). Moreover, the mAb-4arm-PEG-PS/HCPT NPs exhibited enhanced intracellular uptake (∼5 fold that of mAb-4arm-PEG-PS conjugates) and excellent cytotoxicity in vitro. In subsequent Daudi lymphoma xenograft assays, compared with free drugs and mAb-4arm-PEG-PS conjugates, the mAb-4arm-PEG-PS/HCPT NPs inhibited tumor growth more efficiently. Our results indicated the great potential of mAb-4arm-PEG-PS/HCPT NPs for targeted co-delivery of anticancer drugs to solid tumors.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: HER2/EGFR in Cancer Research · Monoclonal and Polyclonal Antibodies Research · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Beijing Key Laboratory of Lignocellulosic Chemistry
Beijing Forestry University
Beijing 100083
P. R. China
Tianjin Key Laboratory of Marine Resources and Chemistry
Tianjin University of Science and Technology
Tianjin
China
Funding
National Natural Science Foundation of China · Tianjin University of Science and Technology
References (32)
Show source-provided references
1. Chari · Angew. Chem., Int. Ed. · 2014 · 53 · 379610.1002/anie.201307628 ↗
2. Zolot · Nat. Rev. Drug Discovery · 2013 · 12 · 25910.1038/nrd3980 ↗
3. Perez · Drug Discovery Today · 2014 · 19 · 86910.1016/j.drudis.2013.11.004 ↗
4. Senter · Nat. Biotechnol. · 2012 · 30 · 63110.1038/nbt.2289 ↗
5. Verma · N. Engl. J. Med. · 2012 · 367 · 178310.1056/NEJMoa1209124 ↗
6. Katz · Clin. Cancer Res. · 2011 · 17 · 642810.1158/1078-0432.CCR-11-0488 ↗
7. Anderl · Antibody–Drug Conjugates · 2013 · 5110.1007/978-1-62703-541-5_4 ↗
8. Mcdonagh · Protein Eng., Des. Sel. · 2006 · 19 · 29910.1093/protein/gzl013 ↗
9. Hamblett · Clin. Cancer Res. · 2004 · 10 · 706310.1158/1078-0432.CCR-04-0789 ↗
10. Alley · Curr. Opin. Chem. Biol. · 2010 · 14 · 52910.1016/j.cbpa.2010.06.170 ↗
11. Ducry · Bioconjugate Chem. · 2009 · 21 · 510.1021/bc9002019 ↗
12. Shen · Nat. Biotechnol. · 2012 · 30 · 18410.1038/nbt.2108 ↗
13. McCormack · J. Surg. Res. · 2012 · 173 · e5310.1016/j.jss.2011.09.054 ↗
14. Kunimoto · Cancer Res. · 1987 · 47 · 5944
15. Tacar · J. Pharm. Pharmacol. · 2013 · 65 · 15710.1111/j.2042-7158.2012.01567.x ↗
16. Trail · Antibodies · 2013 · 2 · 11310.3390/antib2010113 ↗
17. Chari · Cancer Res. · 1992 · 52 · 127
18. Hamann · Bioconjugate Chem. · 2002 · 13 · 4710.1021/bc010021y ↗
19. Yurkovetskiy · Cancer Res. · 2015 · 75 · 336510.1158/0008-5472.CAN-15-0129 ↗
20. Lyon · Nat. Biotechnol. · 2015 · 33 · 73310.1038/nbt.3212 ↗
21. Gupta · Chem. Sci. · 2017 · 8 · 238710.1039/C6SC05149A ↗
22. Elsabahy · Chem. Soc. Rev. · 2012 · 41 · 254510.1039/c2cs15327k ↗
23. Maeda · Adv. Drug Delivery Rev. · 2013 · 65 · 7110.1016/j.addr.2012.10.002 ↗
24. Perche · J. Controlled Release · 2012 · 164 · 9510.1016/j.jconrel.2012.09.003 ↗
25. Ahn · Biomaterials · 2015 · 39 · 2310.1016/j.biomaterials.2014.10.069 ↗
26. Kocbek · J. Controlled Release · 2007 · 120 · 1810.1016/j.jconrel.2007.03.012 ↗
27. Dai · J. Mater. Chem. B · 2015 · 3 · 660510.1039/C5TB00900F ↗
28. Liu · RSC Adv. · 2015 · 5 · 5159210.1039/C5RA06253E ↗
29. Shen · J. Am. Chem. Soc. · 2010 · 132 · 425910.1021/ja909475m ↗
30. D’Souza · AAPS PharmSciTech · 2005 · 6 · E32310.1208/pt060242 ↗
31. Lee · Biomaterials · 2009 · 30 · 91910.1016/j.biomaterials.2008.10.062 ↗
32. Marupudi · Expert Opin. Drug Saf. · 2007 · 6 · 60910.1517/14740338.6.5.609 ↗